Alector (ALEC) Share-based Compensation (2018 - 2026)
Alector's (ALEC) quarterly Share-based Compensation came in at $2.9 million in Q1 2026, down 65.18% year-on-year from $8.4 million in Q1 2025, and down 39.95% on a QoQ basis from $4.8 million in Q4 2025.
Alector (ALEC) Share-based Compensation (2018 - 2026) Analysis & Trends
Alector (ALEC) has 9 years of Share-based Compensation data on file, last reported at $2.9 million in Q1 2026.
- On a quarterly basis, Share-based Compensation fell 65.18% year-over-year to $2.9 million in Q1 2026; TTM through Mar 2026 was $21.2 million, a 43.44% decrease from a year earlier, with the FY2025 full-year figure at $26.7 million, down 32.45% from the prior year.
- Share-based Compensation for Q1 2026 stood at $2.9 million, down from $4.8 million in the prior quarter.
- Over the last five years, Share-based Compensation for ALEC reached as high as $12.5 million in Q2 2022 and fell as low as $2.9 million in Q1 2026.
- Historically, Share-based Compensation has averaged $9.3 million across 5 years, with a median of $10.2 million in 2024.
- Across the five-year window, Share-based Compensation jumped 37.45% in 2022 and plunged 65.18% in 2026, its largest moves.
- Year by year, Share-based Compensation stood at $11.0 million in 2022, then climbed by 5.28% to $11.5 million in 2023, then dropped by 11.52% to $10.2 million in 2024, then slumped by 52.58% to $4.8 million in 2025, then tumbled by 39.95% to $2.9 million in 2026.
- Per Business Quant data, the three most recent Share-based Compensation figures were $2.9 million in Q1 2026, $4.8 million in Q4 2025, and $6.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 6.39 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9.26 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 1.18 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 166.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 257.40 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 87.30 Mn |
| 10 | Alector | 164.78 Mn | -41.74 Mn | - | 2.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.91 Mn |
| Mar 31, 2026 | 2.91 Mn |
| Dec 31, 2025 | 4.84 Mn |
| Dec 31, 2025 | 4.84 Mn |
| Sep 30, 2025 | 6.40 Mn |
| Sep 30, 2025 | 6.40 Mn |
| Jun 30, 2025 | 7.06 Mn |
| Jun 30, 2025 | 7.06 Mn |
| Mar 31, 2025 | 8.35 Mn |
| Mar 31, 2025 | 8.35 Mn |
| Dec 31, 2024 | 10.21 Mn |
| Dec 31, 2024 | 10.21 Mn |
| Sep 30, 2024 | 9.04 Mn |
| Sep 30, 2024 | 9.04 Mn |
| Jun 30, 2024 | 9.91 Mn |
| Jun 30, 2024 | 9.91 Mn |
| Mar 31, 2024 | 10.31 Mn |
| Mar 31, 2024 | 10.31 Mn |
| Dec 31, 2023 | 11.54 Mn |
| Dec 31, 2023 | 11.54 Mn |